相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas
Karen M. Chisholm et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma
Agata M. Wasik et al.
LEUKEMIA & LYMPHOMA (2015)
Assessment of SOX11 Expression in Routine Lymphoma Tissue Sections Characterization of New Monoclonal Antibodies for Diagnosis of Mantle Cell Lymphoma
Davide Soldini et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and/or 13q14
Jennifer Chapman-Fredricks et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study
Lena Nordstrom et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Monoclonal B cell lymphocytosis and in situ lymphoma
Kennosuke Karube et al.
SEMINARS IN CANCER BIOLOGY (2014)
Utility and Diagnostic Pitfalls of SOX11 Monoclonal Antibodies in Mantle Cell Lymphoma and Other Lymphoproliferative Disorders
Megan O. Nakashima et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Aberrant Lymphocyte Enhancer-Binding Factor 1 Expression Is Characteristic for Sporadic Burkitt's Lymphoma
Neele Walther et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
CCND2 rearrangements are the most frequent genetic events in cyclin D1- mantle cell lymphoma
Itziar Salaverria et al.
BLOOD (2013)
Unusual concomitant rearrangements of Cyclin D1 and MYC genes in blastoid variant of mantle cell lymphoma: Case report and review of literature
Audrey Delas et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Cyclin D1 Positive Proliferation Centers Do Not Have CCND1 Translocations or Gains and Lack SOX11 Expression
Joel F. Gradowski et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Lina Nygren et al.
BLOOD (2012)
IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas
Harvey A. Greisman et al.
BLOOD (2012)
Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Alba Navarro et al.
CANCER RESEARCH (2012)
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index
Julia Slotta-Huspenina et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Molecular pathogenesis of mantle cell lymphoma
Pedro Jares et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues
Patrick Adam et al.
MODERN PATHOLOGY (2012)
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease
C. Royo et al.
LEUKEMIA (2012)
Early Lymph Node Involvement by Mantle Cell Lymphoma Limited to the Germinal Center Report of a Case With a Novel Follicular In Situ Growth Pattern
Kerstin L. Edlefsen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
Sarah L. Ondrejka et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas
Bevan Tandon et al.
MODERN PATHOLOGY (2011)
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
A. M. Halldorsdottir et al.
LEUKEMIA (2011)
The complex landscape of genetic alterations in mantle cell lymphoma
Cristina Royo et al.
SEMINARS IN CANCER BIOLOGY (2011)
CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus
Shirley Michelle Shiller et al.
CANCER GENETICS (2011)
A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report
Cristiano Krings Rocha et al.
MOLECULAR CYTOGENETICS (2011)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
Mantle Cell Lymphoma 12 Years After Allogeneic Bone Marrow Transplantation Occurring Simultaneously in Recipient and Donor
Beth Christian et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR
Leticia Quintanilla-Martinez et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Ana Mozos et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Time to Treatment Does Not Influence Overall Survival in Newly Diagnosed Mantle-Cell Lymphoma
Heather E. Eve et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Peter Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals
Y. Lecluse et al.
LEUKEMIA (2009)
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
Iwona Wlodarska et al.
BLOOD (2008)
Nuclear expression of the non-B-cell lineage Sox 11 transcription factor identifies mantle cell lymphoma
Sara Ek et al.
BLOOD (2008)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis
Tiemo Katzenberger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression
Christian Herens et al.
BLOOD (2008)
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
Itziar Salaverria et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH
N. Parry-Jones et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Variant t(2;11) (p11.2;q13) without IGK involvement in a case of mantle cell lymphoma
Renata Woroniecka et al.
CANCER GENETICS AND CYTOGENETICS (2007)
A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus
Stefan Gesk et al.
BLOOD (2006)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
Roland A. Ventura et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Cyclin D1-negative mantle cell lymphoma:: a clinicopathologic study based on gene expression profiling
K Fu et al.
BLOOD (2005)
Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient:: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
B Espinet et al.
HUMAN PATHOLOGY (2005)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL):: a clinicopathological study from the European MCL Network
M Tiemann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome
L Michaux et al.
ANNALS OF HEMATOLOGY (2004)
Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR
C Hirt et al.
BLOOD (2004)
Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma
I Wlodarska et al.
LEUKEMIA (2004)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features
SY Hao et al.
MODERN PATHOLOGY (2002)
A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas
MA Belaud-Rotureau et al.
MODERN PATHOLOGY (2002)
Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism
T Reya et al.
IMMUNITY (2000)
分享论文
